Pharmaceutical News

RSS

Several key findings from clinical trial of an investigational Alzheimer's disease treatment

Elan Corporation and Wyeth Pharmaceuticals have announced several key findings from their Phase IIa clinical trial of an investigational Alzheimer's disease (AD) treatment, AN-1792, which were presented in Philadelphia at the 9th International Conference on Alzheimer's Disease and Related Disorders.

22 Jul 2004

Erbitux (cetuximab) combined with irinotecan offers another option for patients who have colorectal cancer

Erbitux (cetuximab), offers another option for patients who have colorectal cancer that resists standard chemotherapy treatment, according to an article written by two Mayo Clinic cancer researchers published in the current edition of the New England Journal of Medicine.

21 Jul 2004

Lower drug prices could eliminate coverage gap in Medicare Prescription Drug Plan

Medicare could eliminate the coverage gap in its prescription drug benefit if it paid pharmaceutical prices comparable to those paid by citizens of Canada, the United Kingdom and France, according to a report by researchers from the Johns Hopkins Bloomberg School of Public Health and Pennsylvania State University

21 Jul 2004

Court ruling favors State over pharmaceutical manufacturers

Nevada Attorney General Brian Sandoval yesterday announced that Washoe County District Court Judge Steven R. Kosach has issued an important ruling in Nevada's Average Wholesale Price (AWP) litigation against numerous pharmaceutical manufacturers including Abbott Labs, Baxter, Bristol-Myers Squibb, Dey, GlaxoSmithKline, and Pharmacia.

21 Jul 2004

A new vaccine that may delay cancer recurrence

A therapeutic cancer vaccine being co-developed by the Ludwig Institute for Cancer Research and the Australian biotech company CSL Limited successfully induced a comprehensive immune response in patients and appeared to delay cancer recurrence

21 Jul 2004

Roche files for application with FDA to market hepatitis C medication Pegasys(R) for chronic hepatitis B treatment

Roche announced today the submission of a supplemental new biologics license application (sBLA) with the U.S. Food and Drug Administration to market Pegasys(R) (peginterferon alfa-2a) for the treatment of chronic hepatitis B (CHB).

21 Jul 2004

Neuro3d identifies candidate compound

The identification of this compound and extension of the research collaboration by J&JPRD further highlights the strength of Neuro3d's internal drug discovery capabilities.

21 Jul 2004

Debate over acetaminophen and acute liver failure

One expert questions the acceptability of the current level of acetaminophen-related injury and death, while another suggests that acetaminophen overdoses are misunderstood.

20 Jul 2004

FDA is proposing to change the new and generic drug review process

The Food and Drug Administration (FDA) is proposing to change the new and generic drug review processes by replacing "approvable letters" and "not approvable letters" with "complete response letters" that provide companies with specific information about what needs to be done before their drugs can be approved for marketing.

20 Jul 2004

Melanotan-1 can induce tanning in human volunteers who are known to tan easily in response to sunlight

An article in the July issue of the Archives of Dermatology reports that Melanotan-1, a synthetic agent similar to the body's hormone that regulates skin pigmentation, can be combined with UV-B light or sunlight, and appears to act synergistically in the tanning response to light.

20 Jul 2004

Levodopa and pramipexole appear to be reasonable options as initial therapy for Parkinson disease

An article in the July issue of the Archives of Neurology reports that the drugs levodopa and pramipexole both appear to be reasonable options as initial therapy for Parkinson disease, but they are associated with different efficacy and adverse effects.

20 Jul 2004

ARICEPT® delays the onset of Alzheimer's among people with mild cognitive impairment

ARICEPT® a popular Alzheimer's drug has been shown to delay the onset of the disease among people with mild cognitive impairment.

19 Jul 2004

New book focuses on pharmaceutical care

Established pharmacists as well as those studying to gain their qualifications will benefit from a new book which focuses on pharmaceutical care in New Zealand.

19 Jul 2004

Statins may help prevent memory loss connected to dementia or Alzheimer’s disease

Statins, drugs widely used to lower cholesterol in patients with heart disease, may also help prevent memory loss connected to dementia or Alzheimer’s disease, say researchers at the University of Alabama at Birmingham.

19 Jul 2004

Drug slows the progression of mild cognitive impairment

For the first time, a drug appears to have a slowing effect - though limited - on the progression from mild cognitive impairment, a memory disorder considered a strong early predictor of Alzheimer’s disease, to Alzheimer’s.

19 Jul 2004

New drugs that can prevent scarring in the eye after glaucoma surgery

Highly innovative new drugs that can prevent scarring in the eye after glaucoma surgery have been discovered by a London-based team of scientists, who report today in the journal Nature Biotechnology.

19 Jul 2004

New compound that is designed to overcome Gleevec resistance

One of the truly spectacular success stories in modern oncology is the development and implementation of Gleevec, a drug that virtually halts the progress of chronic myeloid leukemia. Yet for some patients who harbor particularly stubborn genetic mutations, Gleevec fails miserably.

17 Jul 2004

Pharmaceutical News

Several key findings from clinical trial of an investigational Alzheimer's disease treatment

Erbitux (cetuximab) combined with irinotecan offers another option for patients who have colorectal cancer

Lower drug prices could eliminate coverage gap in Medicare Prescription Drug Plan

Court ruling favors State over pharmaceutical manufacturers

A new vaccine that may delay cancer recurrence

Roche files for application with FDA to market hepatitis C medication Pegasys(R) for chronic hepatitis B treatment

Neuro3d identifies candidate compound

Debate over acetaminophen and acute liver failure

FDA is proposing to change the new and generic drug review process

Melanotan-1 can induce tanning in human volunteers who are known to tan easily in response to sunlight

Levodopa and pramipexole appear to be reasonable options as initial therapy for Parkinson disease

ARICEPT® delays the onset of Alzheimer's among people with mild cognitive impairment

New book focuses on pharmaceutical care

Statins may help prevent memory loss connected to dementia or Alzheimer’s disease

Drug slows the progression of mild cognitive impairment

New drugs that can prevent scarring in the eye after glaucoma surgery

New compound that is designed to overcome Gleevec resistance

Results from clinical trial of TA-NIC, therapeutic vaccine for the treatment of nicotine addiction

3M granted FDA approval for cream to treat superficial basal cell carcinoma

Ghrelin may help reduce obsesity in children with genetic disorder

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Latest News